Hyperglycemia in Respiratory Diseases—Impact and Challenges
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 2397
Special Issue Editor
Interests: interventional pulmonology; pleural diseases; sarcoidosis and other granulomatous diseases; lung cancer; pulmonary vascular diseases
Special Issue Information
Dear Colleagues,
Hyperglycemia (increased blood glucose levels) has become an epidemic disorder worldwide. As it affects multiple organs, hyperglycemia-related complications need to be continuously followed-up and assessed. Macrovascular and microvascular diseases due to hyperglycemia lead to morbidity and mortality, contribute adversely to the quality of life and increase the cost of health care. The respiratory system is one of the most overlooked target organs of hyperglycemia because its clinical relevance is underrecognized and the hyperglycemia–respiratory system association has not been investigated sufficiently. Respiratory diseases, also increasing in prevalence globally, have a bidirectional relationship with hyperglycemia. The pro-inflammatory, proliferative, and oxidative properties of hyperglycemia have been shown to have a significant role in affecting pulmonary vasculature, airways, and lung parenchyma. Although the relevant data suggests some overlapping or shared regulatory mechanisms between hyperglycemia and respiratory diseases, their exact relationships have not yet been shown clearly. Elucidating how hyperglycemia and respiratory diseases impact each other will be beneficial in developing new management strategies. Thus, this Special Issue will focus on the adverse association between hyperglycemia and respiratory diseases, and its clinical impacts and challenges regarding management.
Prof. Dr. Semra Bilaceroglu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
